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A B S T R A C T
Background
Insemination with donor sperm is an option for couples for whom in vitro fertilisation (IVF) or intra-cytoplasmic sperm injection
(ICSI) has been unsuccessful, couples with azoospermia and for single women or same sex couples.
Insemination of sperm can be done via cervical (CI) or intra-uterine (IUI) routes. IUI has been considered potentially more effective
than CI as the sperm bypasses the cervical mucus and is deposited closer to the fallopian tubes. The cost and risks of IUI may be higher
because of the need for sperm preparation and the introduction of foreign material into the uterus.
Donor spermused for artificial insemination ismainly cryopreserved, due to concerns aboutHIV transmission.However, cycle fecundity
is higher for fresh sperm. Insemination is often combined with ovulatory stimulation, with either clomiphene or gonadotrophin. There
may be risks associated with these therapies, such as higher multiple pregnancy rates.
Objectives
To determine whether pregnancy outcomes are improved using intra-uterine insemination in comparison to cervical insemination in
women undergoing artificial insemination with donor sperm.
Search methods
The following databases were searched: the Cochrane Menstrual Disorders and Subfertility Group Specialised Register, CENTRAL
(The Cochrane Library) , MEDLINE, EMBASE, CINAHL and the reference lists of articles retrieved.
Selection criteria
Randomised controlled trials comparing IUI with CI were included. Crossover studies were included if pre-crossover data was available.
Data collection and analysis
Study quality assessment and data extraction were carried out independently by two review authors (DB, JM). Authors of studies that
potentially met the inclusion criteria were contacted, where possible if additional information was needed.
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Main results
The search strategy found 232 articles. Fifteen studies potentially met the inclusion criteria. Four studies were included in this review.
All the included studies used cryopreserved sperm in stimulated cycles. In two studies 134 women had gonadotrophin-stimulated cycles
and in two studies 74 women had clomiphene-stimulated cycles. The evidence showed that IUI after 6 cycles significantly improved
live birth rates (odds ratio (OR) 1.98, 95% confidence interval (CI) 1.02 to 3.86) and pregnancy rates (OR 3.37, 95% CI 1.90 to
5.96) in comparison to cervical insemination. There was no statistically significant evidence of an effect on multiple pregnancies (OR
2.19, 95% CI 0.79 to 6.07) or miscarriages (relative risk (RR) 3.92, 95% CI 0.85 to 17.96).
Authors’ conclusions
The findings of this review support use of IUI rather than CI in stimulated cycles using cryopreserved sperm for donor insemination.
P L A I N L A N G U A G E S U M M A R Y
Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Insemination of donor sperm is a fertility treatment for women who are unable to conceive with their partner or are single. There
are two techniques of insemination; the sperm can be deposited either in the cervix or in the uterus. The purpose of this review is to
determine whether pregnancy outcomes are improved using intra-uterine insemination (IUI) in comparison to cervical insemination
(CI) in women undergoing insemination with donor sperm. Of the 232 studies found, four studies were included in this review. All of
the included studies used cryopreserved sperm. In two studies women had gonadotrophin-stimulated cycles and in two studies women
had clomiphene-stimulated cycles. The rates of live birth and pregnancy improved with IUI. Therefore, this review supports the use of
IUI instead of CI for donor insemination.
B A C K G R O U N D
Artificial insemination with donor sperm is used for various causes
of subfertility. Ten per cent of the couples who try to conceive
a child will not have a spontaneous conception within a year (
Taylor 2003) and can thus be considered subfertile. A part of this
subfertility is due to severe male factor infertility. Insemination
with donor sperm is a method for these couples to overcome the
male factor. Insemination with donor sperm is also an option for
couples for whom in vitro fertilisation (IVF) or intracytoplasmic
sperm injection (ICSI) has been unsuccessful (Gorrill 2003) and
for single women or same sex couples who want to have a child.
There are two techniques of insemination. With cervical insem-
ination (CI) sperm is deposited at the external cervical os, while
with intra-uterine insemination (IUI) the sperm is deposited in
the uterine cavity. IUI may be more effective than CI as the sperm
bypasses the cervical mucus and is deposited closer to the fallop-
ian tubes, which may increase the number of sperm reaching the
site of fertilisation (Ripps 1994). However, IUI may have some
disadvantages. In contrast to CI, the sperm used for IUI need
to be prepared in the laboratory, which leads to a loss of sperm
during the process. There are several preparation techniques, with
no clear evidence that one specific technique is superior to any
other (Boomsma 2004). IUI also requires manipulation with an
intra-uterine catheter, involving the possible introduction of for-
eign material to the uterus. The cost and the risks (infection and
anaphylaxis) of IUI may, therefore, be higher.
The donor sperm used for artificial insemination is mainly cryop-
reserved, due to concern about human immunodeficiency virus
(HIV) transmission: fresh sperm may still be used outside of the
fertility clinic by single women or same sex couples who obtain
donor sperm from an acquaintance. The use of cryopreserved
sperm, quarantined for six months, is the standard technique
(British 1999).However, cycle fecundity is lower for cryopreserved
sperm than for fresh sperm (Subak 1992). This is due to detri-
mental effects of the freeze-thaw procedure as structural and func-
tional changes result in a decrease in sperm motility, velocity and
viability (Sharma 1997).
Artificial insemination is often combined with ovulation stimu-
lation therapy. This can be achieved with clomiphene, an anti-
estrogen, or with gonadotrophin. Through the use of these drugs
the follicular growth is stimulated. There are risks associated with
these therapies, such as multiple pregnancy rates that range be-
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tween 10% and 40% (Fauser 2005) and ovarian hyperstimulation
syndrome (Delvigne 2002).
The purpose of this review was to collect evidence on the compar-
ison of CI and IUI. This review is an update of a previous review
(O’Brien 1998), according to contemporary Cochrane guidelines
(Higgins 2006).
O B J E C T I V E S
To determine whether pregnancy outcomes are improved using
intra-uterine insemination in comparison to cervical insemination
in women undergoing artificial insemination with donor sperm.
M E T H O D S
Criteria for considering studies for this review
Types of studies
• Only truly randomised trials were included. Trials with
quasi-randomisation were excluded.
• Crossover trials were included only if pre-crossover data was
obtained.
Types of participants
• Women undergoing donor insemination for any reason,
including couples with male factor infertility, couples with a
history of failed IVF or ICSI, single women, same sex couples.
Types of interventions
• IUI versus CI in natural cycles with cryopreserved sperm
• IUI versus CI in clomiphene-stimulated cycles with
cryopreserved sperm
• IUI versus CI in gonadotrophin-stimulated cycles with
cryopreserved sperm
• IUI versus CI in natural cycles with fresh sperm
• IUI versus CI in clomiphene-stimulated cycles with fresh
sperm
• IUI versus CI in gonadotrophin-stimulated cycles with
fresh sperm
Types of outcome measures
Main outcome
• Live birth rate per woman after all cycles
Secondary outcomes
• Live birth rate per woman after one treatment cycle
• Ongoing pregnancy rate per woman after one treatment
cycle
• Pregnancy rate per woman after one treatment cycle
• Ongoing pregnancy rate per woman after all cycles
• Pregnancy rate per woman after all cycles
Adverse outcomes
• Miscarriage rate per woman
• Ectopic pregnancy rate per woman
• Multiple pregnancy per woman
• Infection rate per woman
• Adverse effects rate per woman
Outcomes as stated by a study were also assessed.
Search methods for identification of studies
We searched the following sources for all reports that described (or
might have described) randomised controlled trials of IUI in com-
parison with CI: Cochrane Menstrual Disorders and Subfertility
Group Specialised Register, Cochrane Central Register of Con-
trolled Trials (CENTRAL) (The Cochrane Library 2006, Issue 4),
MEDLINE (1966 to week 3, 2007), EMBASE (1980 to week 3,
2007), CINAHL (1982 to week 50, 2006) and the reference lists
of articles retrieved.
We used the search strategy developed by theMenstrual Disorders
andSubfertilityGroup (seeReviewGroupdetails inTheCochrane
Library for more information). The specific search strings used are
listed below.
MEDLINE
1 randomized controlled trial.pt.
2 controlled clinical trial.pt.
3 Randomized controlled trials/
4 random allocation/
5 double-blind method/
6 single-blind method/
7 or/1-6
8 clinical trial.pt.
9 exp clinical trials/ )
10 (clin$ adj25 trial$).ti,ab,sh.
11 ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or
mask$)).ti,ab,sh.
12 placebos/
13 placebo$.ti,ab,sh.
14 random$.ti,ab,sh.
15 Research design/
16 or/8-15
17 animal/ not (human/ and animal/)
18 7 or 16
19 18 not 17
20 exp Insemination, Artificial/
21 inseminat$.ti,ab,sh.
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22 eutelegenesis.ti,ab,sh.
23 or/20-22
24 IUI.ti,ab,sh.
25 intrauterine.ti,ab,sh.
26 intra-uterine.ti,ab,sh.
27 or/24-26
28 cervical.ti,ab,sh.
29 intracervical.ti,ab,sh.
30 intra-cervical.ti,ab,sh.
31 pericervical.ti,ab,sh.
32 peri-cervical.ti,ab,sh.
33 cap.ti,ab,sh.
34 or/28-33
35 23 and 27 and 34
36 19 and 35
37 from 36 keep 1-58
EBM Reviews - Cochrane Central Register of Controlled Trials
(CENTRAL)
1 artificial insemination/ or intrauterine insemination/
2 inseminat$.mp.
3 or/1-2
4 intrauterine insemination/
5 IUI.mp.
6 intrauterine.mp.
7 intra-uterine.mp.
8 or/4-7
9 cervical.mp.
10 intracervical.mp.
11 intra-cervical.mp.
12 pericervical.mp.
13 peri-cervical.mp.
14 cap.mp.
15 or/9-14
16 3 and 8 and 15
17 from 16 keep 1-51
CINAHL - Cumulative Index to Nursing & Allied Health Liter-
ature
1 artificial insemination/ or intrauterine insemination/
2 inseminat$.mp.
3 or/1-2
4 intrauterine insemination/
5 IUI.mp.
6 intrauterine.mp.
7 intra-uterine.mp.
8 or/4-7
9 cervical.mp.
10 intracervical.mp.
11 intra-cervical.mp.
12 pericervical.mp.
13 peri-cervical.mp.
14 cap.mp.
15 or/9-14
16 3 and 8 and 15
17 Controlled study/ or randomized controlled trial/
18 double blind procedure/
19 single blind procedure/
20 crossover procedure/
21 drug comparison/
22 placebo/
23 random$.ti,ab,hw,tn,mf.
24 latin square.ti,ab,hw,tn,mf.
25 crossover.ti,ab,hw,tn,mf.
26 cross-over.ti,ab,hw,tn,mf.
27 placebo$.ti,ab,hw,tn,mf.
28 ((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or
mask$)).ti,ab,hw,tn,mf.
29 (comparative adj5 trial$).ti,ab,hw,tn,mf.
30 (clinical adj5 trial$).ti,ab,hw,tn,mf.
31 or/17-30
32 nonhuman/
33 animal/ not (human/ and animal/)
34 or/32-33
35 31 not 34
36 16 and 35
37 from 36 keep 1
EMBASE
1 artificial insemination/ or intrauterine insemination/
2 inseminat$.mp. 3 or/1-2
4 intrauterine insemination/
5 IUI.mp.
6 intrauterine.mp.
7 intra-uterine.mp.
8 or/4-7
9 cervical.mp.
10 intracervical.mp.
11 intra-cervical.mp.
12 pericervical.mp.
13 peri-cervical.mp.
14 cap.mp.
15 or/9-14
16 3 and 8 and 15
17 Controlled study/ or randomized controlled trial/
18 double blind procedure/
19 single blind procedure/
20 crossover procedure/
21 drug comparison/
22 placebo/
23 random$.ti,ab,hw,tn,mf.
24 latin square.ti,ab,hw,tn,mf.
25 crossover.ti,ab,hw,tn,mf.
26 cross-over.ti,ab,hw,tn,mf.
27 placebo$.ti,ab,hw,tn,mf.
28 ((doubl$ or singl$ or tripl$ or trebl$) adj5 (blind$ or
mask$)).ti,ab,hw,tn,mf.
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29 (comparative adj5 trial$).ti,ab,hw,tn,mf.
30 (clinical adj5 trial$).ti,ab,hw,tn,mf.
31 or/17-30
32 nonhuman/
33 animal/ not (human/ and animal/)
34 or/32-33
35 31 not 34
36 16 and 35
37 from 36 keep 1-85
Data collection and analysis
DEBesselink and JMarjoribanks independently selected the trials
to be included according to the above-mentioned criteria. They
also independently extracted all data. Disagreements were resolved
by discussionwith Professor Farquhar as referee. ProfessorDr JAM
Kremer acted as a clinical expert.
Included trials were analysed for the following quality criteria and
methodological details. A quality table was made to assess the
methodology. If additional information was needed, the authors
of the articles were contacted.
Trial characteristics
• Quality of allocation concealment (score according to
Cochrane standards)
• Method of randomisation
• Crossover or parallel design
• Number of women eligible, randomised, excluded or lost to
follow up
• Details on dropouts
• Presence of a power calculation
• Number and percentage of cancelled cycles
• Duration, timing and location (single or multicentre) of the
study
• Whether an intention-to-treat analysis was done or could
be extracted
• Funding
Types of participants
• Indication for insemination
• Women’s age
• Duration of subfertility
Types of ovulation cycles
• Natural cycles
• Clomiphene-stimulated cycles
• Gonadotrophin-stimulated cycles
SAME AS ABOVE (CHARACTERISTICS OF INCLUDED
STUDIES)
Statistical analysis
Binary data for each comparison and each study are summarised
in two-by-two tables and expressed as odds ratios (OR) with 95%
confidence intervals (CI). Data was pooled and a meta-analysis
performed with RevMan software using the Peto-modified Man-
tel-Haenszel method and a fixed-effect model.
Statistical heterogeneity between the results of different studies was
examined by inspecting the scatter in the data points on the graphs
and the overlap in their confidence intervals, and by checking the
Chi-squared tests and I2 statistic. When statistically significant
heterogeneity was found (Chi-squared test P < 0.05) a random-
effects model would have been used as well as the fixed-effect
model.
When substantial heterogeneity was detected (I2 greater than
75%) or if trials differ markedly with respect to clinical or design
characteristics, then sensitivity analyses would have been under-
taken. To detect publication bias a funnel graph, plotting effect
size versus sample size, would have been performed if sufficient
studies were available.
Sensitivity analyses
Specific differences that we planned to explore were trials with
adequate methodology versus those of poor methodology; where
adequate methodology was defined for this purpose as secure ran-
domisation, adequate allocation concealment, analysis by inten-
tion to treat, and losses to follow up of less than 10%. Further sen-
sitivity analyses would have been performed on trials that might
differ from others with respect to prognostic factors at baseline.
Sensitivity analyses would also have compared couples with or
without a history of infertility.
Subgroup analyses
No subgroup analyses were done.
Changes to original review
There are two major changes to the original review. First, stud-
ies with a crossover design were only included if they could pro-
vide pre-crossover data. Authors were contacted to obtain the pre-
crossover data, if necessary. The reason for the change is that stud-
ies with a crossover design are not appropriate when the outcome
is irreversible (Higgins 2006), as it is with pregnancy. The out-
come will prevent the woman from crossing over and an intra-
participant comparison will be impossible. Furthermore, women
who remain under treatment after the first cycle have, on average,
lower fecundity that those who conceived during the first cycle;
because those of highest fecundity are no longer ’at risk’ of preg-
nancy. All these factors can lead to an exaggeration of the more
successful treatment effect (Lechmacher 1991).
The other major change in the present review is that the outcomes
were stated per woman instead of per cycle. This way the compared
groups are statistically independent.
R E S U L T S
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Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The search strategy described above found 85 articles with EM-
BASE, 58 articles with MEDLINE, 51 articles with CENTRAL,
37 articles in the Cochrane Menstrual Disorders and Subfertility
Group Specialised Register and one article with CINAHL. DB
screened the findings and retrieved 15 studies that potentially met
the inclusion criteria. DB and JM checked these in full text for
eligibility and found four to be eligible.
Included studies
Four studies were included in this review. All of the included
studies used cryopreserved sperm. In two studies women had go-
nadotrophin-stimulated cycles (Wainer 1995; Matorras 1996). In
the other two studies women had clomiphene-stimulated cycles
(Patton 1992; Hurd 1993)
Characteristics of participants
• Participants
In the two studieswhere gonadotrophin stimulationwas used there
were a total of 134 women. Both studies inseminated a maximum
of six times (Wainer 1995; Matorras 1996). Of the studies with
clomiphene stimulated cycles, one had 48 women in the studies
and inseminated also a maximum of six cycles (Patton 1992). The
other study using clomiphene-stimulated cycles was a crossover
study (Hurd 1993) with 26 women receiving CI or IUI only once
before crossing over.
• Indication
All studies included couples with male factor infertility namely
azoospermia and oligospermia. Wainer 1995 also included one
couple with a genetic indication and two studies also included
single women (Patton 1992; Hurd 1993). Only Matorras 1996
reported criteria for a maximum sperm count.
• Inclusion criteria
All the studies performed hysterosalpingography on the women
(Patton 1992; Hurd 1993; Wainer 1995; Matorras 1996) but
Patton 1992 performed them only on women with a historical
risk and excluded the women with an abnormal hysterosalpin-
gography. Three studies evaluated women with basal body tem-
perature charts (Patton 1992; Hurd 1993; Wainer 1995). Hurd
1993 also evaluated 15 patients by laparoscopy of whom seven
were treated before the start of the study with laser laparoscopy
for tubal adhesions (two women) or endometriosis grade I (two
women) or grade II (three women). Women were excluded who
had ovulatory dysfunction not corrected by clomiphene. Patton
1992 performed an additional urinary luteinising hormone (LH)
assay on the women.
Matorras 1996 performed an endometrial biopsy, determination
of P and PRL and sperm analysis. Couples were included if they
had an infertility history of > 2 years, at least one patent tube,
woman’s age < 40 years and an abnormal sperm analysis of < 1.5
X 106 motile sperm after Percoll preparation. Wainer 1995 per-
formed an additional analysis of the cervical mucus and hormonal
screening. Women were included in the study if they had no other
fertility problem except slight ovulation dysfunction.
• Age
One study could not provide us with the ages of the separate
intervention groups before crossover, but the overall mean (SD)
age was 32 (4) years (Hurd 1993). In the other three studies the
ages of the women were similar with means between 30 and 32
years.
• Duration of infertility
Only one study stated the average duration of infertility (Matorras
1996). The couples in the CI group had an infertility history (SD)
of 5.97 (3.13) years and the couples in the IUI group had an
infertility history (SD) of 7.81 (3.75) years.
• Previous treatment
Wainer 1995 was the only study that stated women’s previous
treatments. There was one woman in the CI group who had a
live birth after CI and two women in the IUI group who had
previously received CI, of whom one woman had a live birth and
one woman had a miscarriage.
• Characteristics of intervention
None of the included studies used fresh sperm for the insemina-
tion. All of the studies stimulated cycles with either clomiphene
or gonadotrophin. Only one study stated the number of women
receiving cycle induction per intervention group, in which 13 of
22 women in the CI group and 6 of 28 women in the IUI group
received clomiphene (Patton 1992). In the other study where
clomiphene was used, 23 of 41 women received treatment (Hurd
1993) but it was not stated per intervention group. The study also
compared IUI and CI with a third treatment namely intratubal
insemination combined with IUI.
The two studies that compared IUI versus CI in gonadotrophin-
stimulated cycles did not state how many women, in total or
in each group, received gonadotrophin (Wainer 1995; Matorras
1996).
The studies that used clomiphene for cycle induction inseminated
both intervention groups at LH+1day (Patton 1992;Hurd1993).
The studies that used gonadotrophin inseminated the CI group
twice at LH + 12 hours and 36 (Matorras 1996) or 38 hours
(Wainer 1995) and the IUI group once at 36 hours (Matorras
1996) or 38 hours (Wainer 1995).
• Characteristics of outcome measures
All of the studies defined pregnancy by the visualisation of a ges-
tational sac. Two studies also measured serum human chorionic
gonadotrophin (hCG) to confirm pregnancy (Patton 1992; Hurd
1993).
The primary outcome of live birth rates was presented by all but
one study (Hurd 1993; Wainer 1995; Matorras 1996). All studies
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reported pregnancy rates per woman after all insemination cycles.
Two studies also provided pregnancy rates per woman after one
treatment cycle (Patton 1992;Wainer 1995) aswell as the crossover
study as it provided data of only one cycle (Hurd 1993).
Only one study failed to report any adverse outcomes (Patton
1992). The other three studies provided data on miscarriage and
multiple pregnancy rates (Hurd 1993; Wainer 1995; Matorras
1996). One study also reported ectopic rates (Hurd 1993). None
of the studies reported on infections or other adverse effects of the
inseminations.
Risk of bias in included studies
Excluded studies
Eleven studies were excluded. Studies that were unable to provide
pre-crossover data were excluded from this update (Urry 1988;
Byrd 1990; Patton 1990; Ract 1992; Peters 1993; Alexander 1994;
Williams 1995; Pistorius 1996; Carroll 2001). This included stud-
ies that were in the original Cochrane review. The reasons for ex-
cluding these crossover studies are outlined in the ’Methods of the
review’ section. Carroll 2001 and Peters 1993 were excluded be-
cause they used quasi-randomisation methods; both studies allo-
cated by alternation. Le Lannou 1989 and Walker 1993 were ex-
cluded because of theirmethod of comparison; they compared IUI
using gonadotrophin-stimulated cycles with CI using un stimu-
lated cycles (Walker 1993) or with a proportion (Le Lannou 1989)
of un stimulated cycles. This made it impossible to judge the spe-
cific effects of IUI versus CI per se.
• Allocation concealment
Hurd 1993 and Matorras 1996 used opaque, consecutively num-
bered lists to conceal allocation and provided no further infor-
mation. The other studies did not state if or how allocation was
concealed (Patton 1992; Wainer 1995).
• Randomisation method
Three studies used random number lists to randomise the women
(Hurd 1993; Wainer 1995; Matorras 1996). It was not clear how
the randomisation procedure in Patton 1992 was performed.
• Study design
Three studies used a parallel design (Patton 1992; Wainer 1995;
Matorras 1996). Attempts were made to contact authors of studies
with a crossover design to obtain pre-crossover data. Only one
study provided pre-crossover data and could therefore be included
in the review (Hurd 1993).
• Blinding of treatment
The procedure of blinding was not mentioned in any of the stud-
ies.
Blinding of donor selection was stated in only one study (Wainer
1995), where centres supplying the semen were blind to the
method of insemination.
• Dropouts and intention-to-treat analysis
Two studies reported no dropouts (Hurd 1993; Matorras 1996).
One study did not report dropout rates (Wainer 1995). In Patton
1992 seven women dropped out before the first insemination and
12 women were eliminated from analyses; four were excluded be-
cause of more than a single route of insemination, two women
because they received more than one insemination per cycle, four
women because of uterine structural anomalies and two women
were excludedbecause they used gonadotrophin.Hurd1993 stated
in the correspondence that analysis was done by intention to treat.
• Power calculation
OnlyMatorras 1996 reported a power calculation but provided no
further details. Hurd 1993 did not perform a power calculation.
Wainer 1995 and Patton 1992 did not mention a power calcula-
tion.
• Cancelled cycles
None of the studies reported information on cancelled cycles.
• Duration, timing and location (single or multicentre) of
the study
The included studies were all single-centre studies.
Effects of interventions
None of the included studies used fresh sperm. Therefore there are
no results for the interventions comparing IUI and CI with fresh
sperm. None of the included studies conducted inseminations in
natural cycles.
IUI versus CI in stimulated cycles with cryopreserved sperm
All the included studies used either clomiphene or gonadotrophin-
stimulated cycles with cryopreserved sperm. In total they com-
pared 207women, ofwhom26hadonly one insemination because
of the crossover design of the trial. The other 181 women received
up to six inseminations. The outcomes discussed in this section
were only those where clomiphene as well as gonadotrophin-stim-
ulated cycles were pooled. Pooled data for the separate stimulation
regimes are discussed later in the review.
• Live birth rate per woman after all treatment cycles
Three studies with a total of 157 women reported live birth as
an outcome. IUI gives a statistically significant higher live birth
rate (OR 1.98, 95% CI 1.02 to 3.86) statistical heterogeneity (P
= 0.84, I2 = 0%).
• Pregnancy rate per woman after one treatment cycle
Three studies with a total of 119 women reported pregnancy rate
per woman after one treatment cycle. The difference was not sta-
tistically significant, there were five pregnancies in the CI group
(n = 55) and 12 pregnancies in the IUI group (n = 64) (OR 2.12,
95%CI 0.76 to 5.95) statistical heterogeneity (P = 0.64, I2 = 0%).
• Pregnancy rate per woman after all treatment cycles
All the included studies reported pregnancy rate as an outcome.
IUI gives a statistically significant higher pregnancy rate (OR 3.37,
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95% CI 1.90 to 5.96) statistical heterogeneity (P = 0.42, I2 =
0.0%).
• Adverse outcomes
Three trials reported miscarriage and multiple pregnancy rates per
woman but the differences found were not significant. None of the
studies reported ectopic pregnancies rate, infection rate or adverse
effects rate per woman.
• Miscarriage rate per woman
Three included studies reported miscarriage rate as an outcome.
In total there were seven miscarriages. The difference was not
statistically significant (OR 3.92, 95%CI 0.85 to 17.96) statistical
heterogeneity (P = 0.78, I2 = 0%).
• Multiple pregnancy rate per woman
Three included studies reported multiple pregnancy as an out-
come. There were 12 multiple pregnancies in the IUI group and
fivemultiple pregnancies in the CI group. The difference inmulti-
ple pregnancy rate was not statistically significant (OR 2.19, 95%
CI 0.79 to 6.07) statistical was heterogeneity (P = 0.87, I2 = 0%)
IUI versus CI in clomiphene-stimulated cycles with cryopre-
served sperm
There were two included studies that compared IUI and CI in
clomiphene-stimulated cycles with cryopreserved sperm (Patton
1992;Hurd 1993). In total they compared 76 women of whom 26
had only one insemination, because of the crossover design of the
trial. The other 50 women could receive up to six inseminations.
• Live birth rate per woman after all treatment cycles
One study reported pregnancy rate after all treatment cycles, but
only one cycle was performed. The study reported one pregnancy
in the IUI group (n = 13) as well as in the CI (n = 13) group (OR
1.00, 95% 0.06 to 16.93).
• Live birth rate per woman after one treatment cycle
One study reported pregnancy rate after one treatment cycle and
reported one pregnancy in the IUI group (n = 13) as well as in the
CI (n = 13) group (OR 1, 95% 0.06 to 16.93).
• Ongoing pregnancy rate per woman after one treatment
cycle
None of the studies reported ongoing pregnancy rate per woman
after one treatment cycle.
• Pregnancy rate per woman after one treatment cycle
The pregnancy rates after one insemination are higher for IUI,
but the difference is not statistically significant (OR 2.62, 95% CI
0.76 to 9.07: statistical heterogeneity P = 0.46, I2 = 0%).
• Ongoing pregnancy rate per woman after all cycles
None of the studies reported ongoing pregnancy rate per woman
after all treatment cycles.
• Pregnancy rate per woman after all treatment cycles
The two included studies reported pregnancy rate per woman
was an outcome. The pregnancy rate in the IUI group was 20
per 41 women compared with 5 per 35 women in the CI group.
The difference is statistically significant higher, but with a wide
confidence interval (OR 5.47, 95% CI 1.95 to 15.35 :statistical
heterogeneity P = 0.21, I2 = 37.4%).
• Adverse outcomes
One trial (n = 26) reported no miscarriages, ectopic pregnancy’s
or multiple pregnancies after one insemination. The adverse out-
comes infection rate and adverse effects were not reported in the
other study.
IUI versus CI in gonadotrophin-stimulated cycles with cryop-
reserved sperm
Two of the included studies compare IUI and CI in go-
nadotrophin-stimulated cycles with cryopreserved sperm in 131
women for a maximum of six cycles per woman. (Wainer 1995,
Matorras 1996)
• Live birth rate per woman after all treatment cycles
Both included studies reported live birth as an outcome. IUI gave
a statistically significant higher live birth rate (OR 2.07, 95% CI
1.04 to 4.10:statistical heterogeneity P = 0.74, I2 = 0%).
• Live birth rate per woman after one treatment cycle
None of the studies reported live birth rate per woman after one
treatment cycle.
• Ongoing pregnancy rate per woman after one treatment
cycle
None of the studies reported ongoing pregnancy rate per woman
after one treatment cycle.
• Pregnancy rate per woman after one treatment cycle
One study reported pregnancy rate per woman after one treatment
cycle. There were two pregnancies in the CI group (n = 20) and
three pregnancies in the IUI group (n = 23) (OR 1.34, 95% CI
0.21 to 8.47).
• Ongoing pregnancy rate per woman after all treatment
cycles
None of the studies reported ongoing pregnancy rate per woman
after all treatment cycles.
• Pregnancy rate per woman after all treatment cycles
Both included studies reported pregnancy rate as an outcome. IUI
gave a statistically significant higher pregnancy rate (OR 2.72,
95% CI 1.37 to 5.40: statistical heterogeneity P = 0.92, I2 = 0%).
• Adverse outcomes
Both trials reported miscarriage and multiple pregnancy rates per
woman but the differences found were not significant. None of the
studies reported ectopic pregnancies rate, infection rate or adverse
effects rate per woman.
• Miscarriage rate per woman
Both included studies reported miscarriage rate as an outcome.
In total there were 7 miscarriages. The difference between groups
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was not statistically significant (OR 3.92, 95% CI 0.85 to 17.96:
statistical heterogeneity P = 0.78, I2 = 0%).
• Multiple pregnancy rate per woman
Both included studies reportedmultiple pregnancy as an outcome.
There were 12 multiple pregnancies in the IUI group and five
multiple pregnancies in the CI group. This difference in multiple
pregnancy rate was not statistically significant (OR 2.19, 95% CI
0.79 to 6.07:statistical heterogeneity P = 0.87, I2 = 0%).
D I S C U S S I O N
The aim of this systematic review was to assess the evidence on
the comparative effectiveness of CI and IUI with donor sperm.
Although ICSI has become an important treatment in male factor
infertility, donor sperm insemination remains an option for some
couples with azoospermia, a same sex relationship or for single
women. IUI has come to replace CI in many centres as a result of
clinical trials over the years. This review assessed the value of this
change based on the results of randomised clinical trials.
Summary of main results
Few true randomised clinical trials were available. Comparisons
could only be made with two interventions and a few outcomes
could be pooled. In up to six cycles of insemination, in both
clomiphene and gonadotrophin-stimulated cycles with cryopre-
served sperm, live birth rates and pregnancy rates were higher us-
ing IUI. There was no evidence of significant differences for any of
the adverse outcomes. No studies were included that inseminated
with fresh sperm or in natural cycles. Therefore, there remains a
gap in the evidence on these subjects.
Quality of evidence
See Table 1
The methodology of the included trials was of moderate quality.
All studies performed randomisation, but in one trial the method
used was unclear. The allocation was concealed in two trials and
two trials did not state whether it was concealed or not. This could
cause selection bias and an overestimation of the results (Daya
2003; Vail 2003).
One study reported couples that dropped out (Patton 1992),
mostly because of protocol violation. No intention-to-treat anal-
ysis was performed but the drop-outs were equally distributed in
both intervention groups. It is therefore unlikely that the dropouts
affected the outcome of the trial in a major way. In the same study,
the number of suboptimal cycles was unequally distributed and
more CI than IUI couples had to receive clomiphene treatment.
This may have favoured IUI in the trial and possibly in the meta-
analysis. We were unable to perform an intention-to-treat analysis
because we unable to retrieve additional data on the women who
dropped out.
The blinding of the procedure is not mentioned in the studies but
it would have been difficult to blind the insemination technique
to the clinicians. Women may notice a difference because of the
more invasive procedure of IUI. Because of these problems in
the blinding procedure of the insemination technique, bias is a
possibility but its effect is difficult to detect or assess.
The study populations in the trials were small and in three of the
four included studies no power calculation was performed. In total
we were able to pool results for 210 women of whom 26 women
received an insemination only once. The odds ratios from the
pooled data have wide confidence intervals because of this small
number of women. The evidence found is, therefore, not strong
and is imprecise.
Potential biases in the review process
It is a possibility that single women or the women of couples with
the indication of azoospermia who were included in the studies
were on average more fertile than women of couple with the in-
dication oligospermia. Women with an oligospermic partner have
a chance of conceiving a child naturally and, therefore, women
with a good or high fertility may not need donor insemination.
Women who have no male partner or have an azoospermic part-
ner may have a better fertility on average and may be more likely
to get pregnant with insemination. The two trials that used stim-
ulated cycles with clomiphene included more azoospermic than
oligospermic couples, but the distribution of the couples was un-
clear and, therefore, the effect on the outcomes as well (Patton
1992; Hurd 1993). Of the trials that stimulated cycles with go-
nadotrophin, one trial stated that azoospermic and oligospermic
couples were equally randomised (Matorras 1996); Wainer 1995
only included sterile men and one couple with a genetic indica-
tion. It is not likely that the fertility of the couples influenced the
outcomes in these trials.
The inclusion criteria can also influence the pregnancy outcomes
of the studies. Couples with a longer history of infertility are more
likely to have lower fertility. One study reported the duration of
the subfertility of the included couples. On average women in the
IUI group had a longer history of subfertility. But in spite of this
disadvantage the IUI group had higher pregnancy rates.
Women who received previous treatment but did not conceive
may also have a lower fertility. These characteristics are described
in one study but it was not possible to assess if this biased the
results.
The fecund ability of women declines with increasing age (Dunson
2004), which probably results in a lower overall pregnancy rate
per cycle for intrauterine insemination with frozen donor sperm
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(Ferrara 2002). The woman’s age is therefore an important deter-
minant for the success rate of insemination. The women in the
included studies were of a similar mean age, so age is not likely to
have caused bias.
The characteristics of the sperm used for insemination may in-
fluence the success of the insemination. There is insufficient evi-
dence to state that a superior sperm preparation technique exists
(Boomsma 2004). The number of motile sperm used for the in-
semination differed between the studies, from 1.58 million post
wash in Wainer to 43.7 million in Patton. The number of sperm
used in the trials for either CI or IUI did not differ greatly. It is
difficult to assess what the influence of the differences in sperm
count may have been on the outcomes because of different ovu-
lation stimulation regimes. But the numbers used in the studies
for IUI are all greater than the suggested threshold of 0.8 to five
million motile sperm after washing (van Weert 2004).
The optimal timing for IUI in gonadotrophin-stimulated cycles
is between 32 hours and 38 hours after the hCG administra-
tion (Ragni 2004). Both Matorras and Wainer performed the IUI
within this preferred time limit. The CI was performed twice at
12 and 36 to 38 hours after the hCG administration; an optimal
timing for CI is not known. It is possible that the double cervical
insemination favoured CI, but IUI still resulted in a higher live
birth and pregnancy rate.
The optimal timing for IUI or CI in clomiphene-stimulated cy-
cles is not clear. Both studies performed the inseminations at the
same time (Patton 1992; Hurd 1993) and therefore do not give
clinical heterogeneity or bias. It is possible that CI and IUI are
best performed at different times after the LH surge for optimal
results. The timing of LH + 1 can bias results towards either IUI
or CI.
In contrast with IUI, the success of CI may depend upon the state
of the cervical mucus. The optimal state of mucus may be only
present for a short period of time. None of the studies evaluated
the state of the mucus before the insemination, which could result
in suboptimal conditions for CI and, as a result, lower pregnancy
rates.
Agreements and disagreements with other studies
The overall 2002 pregnancy rates in Europe for IUI are 16.6%
per initiated cycle, ranging between 6.7% and 37.5% (ESHRE
2006). This is the average pregnancy rate for women under 40
years irrespective of the ovulation induction method or number of
previous inseminations. The pregnancy rates per cycle for most of
the included studies were higher, namely 23% (Patton 1992), 20%
(Wainer 1995) and 24% (Matorras 1996). Only Hurd 1993 had
a lower pregnancy rate per cycle, of 8%, but this is the pregnancy
rate of the first insemination cycle only.
The higher multiple pregnancy rates for IUI reported in this re-
view, althoughnot significant, are in agreementwithTur 1997.Tur
performed a retrospective non-random analysis of insemination
techniques using donor sperm and found a significantly higher
multiple pregnancy rate in IUI with gonadotrophin stimulation
in comparison to CI with gonadotrophin stimulation.
Discussion of crossover trials
Unfortunately we had to exclude most of the potentially eligible
trials because they had a crossover design without separate pre-
crossover data being available. The crossover design is not suitable
for fertility research and the overall methodology quality of the
studies was also poor in other respects. Two studies randomised by
alternation (Peters 1993; Carroll 2001) and in four other trials it
was unclear (Patton 1990; Ract 1992; Alexander 1994; Pistorius
1996). There was no mention of concealment of allocation in any
of the studies.
In spite of these methodological problems it would be a loss
of information not to mention the results in this review. The
crossover studies included women with natural, clomiphene or
gonadotrophin-stimulated cycles. A total of 1171 cycles were per-
formed with cryopreserved sperm and results are presented in
Figure 1. Two studies were excluded from the table because they
allocated by alternation (Peters 1993; Carroll 2001). Overall the
studies showed a higher pregnancy rate per cycle with IUI (11.2%)
than CI (5.6%). No statistically significant differences were found
in miscarriage rates. These results are comparable with the find-
ings of this review, that IUI is a more effective than CI with cry-
opreserved sperm.
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Figure 1. Table 2.
The one study that used fresh sperm found no statistically signif-
icant difference in pregnancy rate per cycle between IUI and CI
(Patton 1990). The results are shown in Figure 2
Figure 2. Table 3.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In clinical practice, IUI is a widely usedmethod to overcome fertil-
ity problems. CI is potentially a less invasive technique and could
be useful if shown to have similar effectiveness to IUI. However
this review provides evidence, albeit from a small number of trials,
that IUI improves pregnancy outcomes compared with CI with no
evidence of increased risk of adverse effects. Therefore, no change
in policy for IUI is recommended.
Implications for research
As most eligible trials for the review had to be excluded because of
their crossover design, it is important that further fertility research
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on this subject should be performed with a parallel study design.
It is unlikely that further studies comparing CI with IUI will be
undertaken in the future but if future studies are contemplated
the following issues should be carefully addressed:
• parallel design
• rates per women
• allocation concealment
• randomisation
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Hurd 1993
Methods Randomisation: random number lists
Allocation concealment: Using opaque consecutively numbered envelopes
Study design: crossover
Number of women randomised: 41
Number of dropouts none
Participants Participants: pre-crossover; CI 13 women; IUI 13 women; transcervical intratubal insemination combined
with IUI 15 women
Indication: couples with azoospermia, severe oligospermia and single women
Study of couples: Basal Body Temperature, hysterosalpingography. 15 women also had laparoscopy, and
7 of those had laser treatment for tubal adhesions or endometriosis grade I or II
Criteria: excluded: not corrected ovulatory dysfunction
Age: not stated per intervention group (all women; 23 +/- 4 years)
Duration of infertility: not stated
Previous treatment: not stated
Interventions Ovulation induction method: 23 women of 41 had clomiphene -corrected cycles
Timing of insemination: single insemination on LH+1 day
Outcomes Primary outcome: Live birth
Secondary outcome: Pregnancy rate
Adverse outcome: Miscarriage rate, Multiple pregnancy rate, Ectopic pregnancy rate
Notes A third treatment in this three-way study was transcervical intratubal insemination combined with IUI
Pregnancy defined by serum hCG + ultrasound (gestation sac)
Donor sperm was purchased from International Cryogenics
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Matorras 1996
Methods Randomisation: random number table
Allocation concealment: Using opaque consecutively numbered envelopes
Study design: paralel
Number of women randomised: 88
Number of dropouts: none
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Matorras 1996 (Continued)
Participants Participants: 41 CI; 47 IUI
Indication: couples with male infertility; stated as a sperm count of <1,5 X 106 motile sperm after Percoll
preparation
Study of couples:endometrial biopsy, determination of P and PRL, hysterosalpingography and sperm
analysis
Criteria: inclusion: infertility history of >2 years, at least one patent tube, women’s age < 40 years,
an abnormal sperm analysis according to WHO criteria and < 1. 5 million motile sperm after Percoll
preparation
Age: CI 31.89 +/- 3.71 years
IUI 30.78 +/- 3.71 years
Duration of infertility: CI; 5.97 +/- 3.13 years
IUI; 7.81+/- 3.75 years
Previous treatment: not stated
Notes: CI; 48.78% of women with normal infertility studies
IUI; 59.57% of women with normal infertility studies
Interventions Ovulation induction method: gonadotrophin- stimulated cycles in both groups
Timing of insemination: CI; LH+ 12 and +36 hours
IUI; LH+ 36 hours
A maximum of 6 insemination cycles
Outcomes Primary outcome: Live birth per woman after all cycles
Secondary outcome: Pregnancy rate per woman after all cycles
Adverse outcome: Miscarriage rate, Multiple pregnancy rate
Notes Pregnancy defined by the visualisation of a gestational sac at 6th to 7th week of amenorrhoea
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Patton 1992
Methods Randomisation: Randomised, method unclear
Allocation concealment: unclear (B)
Study design: parallel
Number of women randomised: 69 women
Number of dropouts: 9 CI dropouts and 10 ICI dropouts; 7 women dropped out before the first insemina-
tion; 12 were eliminated from analyses for the following reasons: more than a single route of insemination
(4), more than one insemination per cycle (2), uterine structural anomalies (4), gonadotropin use (2)
Participants Participants: CI 22 women
IUI 28 women
Indication: couples with azoospermia, severe oligospermia and single women
Study of couples: Pre-insemination screening included basal body temperature, urinary LH assay, hys-
terosalpingography in women with historical risk
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Patton 1992 (Continued)
Criteria: excluding; women with abnormal hysterosalpingogram
Age: IUI 30.7 +/- 5
ICI 32.0 +/- 5
Duration of infertility: not stated
Previous treatment: not stated
Interventions Ovulation induction method: abnormalities in ovulatory function were treated with clomiphene citrate.
ICI; 13 women with suboptimal cycles, 8 optimal after treatment.
IUI; 6 women with suboptimal cycles, 6 received treatment.
Timing of insemination: Single insemination on LH+1 day
Notes: A maximum of six inseminations per woman
Outcomes Primary outcome:
Secondary outcome: Pregnancy rate per woman after one cycle, pregnancy rate per woman after all cycles
Adverse outcome:
Notes Intention to treat analyses is not stated
Pregnancies were confirmed by standard serum assays of human chorionic gonadotropin and ultrasound
evidence of a gestational sac.
Sperm donors were recruited from the medical community.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Wainer 1995
Methods Randomisation: randomised list
Allocation concealment: unclear
Study design: parallel
Number of women randomised: 43
Number of dropouts: not stated
Participants Participants: CI 20; IUI 23
Indication: couples with sterile men and one couple with a genetic indication
Study of couples:analysis of the cervical mucus, hysterosalpingography, hormonal screening, basal body
temperature chart
Criteria: Women had no other infertility factors accept slight ovulation dysfunction
Age: CI 30 +/- 0.3 years
IUI 31 +/- 0.4 years
Duration of infertility: not stated
Previous treatment: CI; 1 birth after CI
IUI; 1 birth and 1 miscarriage after CI
Notes: CI; 1 miscarriage, 1 abortion
IUI; 1 miscarriage, 1 abortion
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Wainer 1995 (Continued)
Interventions Ovulation induction method: Women with slight ovulation dysfunction were gonadotrophin- stimulated
Timing of insemination: CI; 12 +/- 4 hours and 38 +/- 4 hours after HCG injection
IUI; 38 +/- 4 hours after HCG injection
Notes: Some of the first IC inseminations had only 1 insemination. Women were inseminated for two
successive menstrual cycles followed by a rest cycle to a maximum of six inseminations
Outcomes Primary outcome: Live birth rate per woman after all cycles
Secondary outcome: Pregnancy rate per woman after one cycle, pregnancy rate per woman after all cycles
Adverse outcome: Multiple pregnancy, Miscarriage rate
Notes Pregnancy defined as being visible by ultrasound
Donor sperm was supplied by three different centres
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alexander 1994 1.Crossover
2.Appeared as an abstract only
Byrd 1990 1.Crossover; no pre-crossover data available
2.Allocation concealment not stated
Carroll 2001 1.Randomisation by alternation
2.Crossover; no pre-crossover data available
3.Allocation concealment not stated
Le Lannou 1989 1.Pseudo randomised
2.No distinction between natural and hyperstimulated cycles in control group
Patton 1990 1.Crossover; no pre-crossover data available
2.Allocation concealment not stated
3.Randomisation method not stated
Peters 1993 1.Crossover; no pre-crossover data available
2.Allocation concealment not stated
3.Randomisation by alternation
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(Continued)
Pistorius 1996 1.Crossover; no pre-crossover data available
2.Allocation concealment not stated
3.Randomisation method not stated
Ract 1992 1.Crossover; no pre-crossover data available
2.Allocation concealment not stated
3.Randomisation method not stated
Urry 1988 1.Crossover; no pre-crossover data available
2.Allocation concealment not stated
3.Randomisation method not stated
Walker 1993 1. Stated to be RCT but all patients received CI in the first treatment cycle
2. CI cycles which some patients had undergone before the trial were included in the results
3. Hyperstimulated cycles versus natural cycles
Williams 1995 1.Crossover; no pre-crossover data available
2. Allocation concealment not stated
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D A T A A N D A N A L Y S E S
Comparison 1. IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Live birth rate per woman after
all treatment cycles
3 157 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.98 [1.02, 3.86]
1.1 IUI versus CI in
clomiphene-stimulated cycles
1 26 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.0 [0.06, 16.93]
1.2 IUI versus CI in
gonadotrophin-stimulated
cycles
2 131 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.07 [1.04, 4.10]
2 Live birth rate per woman after
one treatment cycle
1 26 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.0 [0.06, 16.93]
2.1 IUI versus CI in
clomiphene-stimulated cycles
1 26 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.0 [0.06, 16.93]
2.2 IUI versus CI in
gonadotrophin-stimulated
cycles
0 0 Peto Odds Ratio (Peto, Fixed, 95% CI) Not estimable
3 Pregnancy rate per woman after
one treatment cycle
3 119 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.12 [0.76, 5.95]
3.1 IUI versus CI in
clomiphene-stimulated cycles
2 76 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.62 [0.76, 9.07]
3.2 IUI versus CI in
gonadotrophin-stimulated
cycles
1 43 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.34 [0.21, 8.47]
4 Pregnancy rate per woman after
all treatment cycles
4 207 Peto Odds Ratio (Peto, Fixed, 95% CI) 3.37 [1.90, 5.96]
4.1 IUI versus CI in
clomiphene-stimulated cycles
2 76 Peto Odds Ratio (Peto, Fixed, 95% CI) 5.47 [1.95, 15.35]
4.2 IUI versus CI in
gonadotrophin stimulated
cycles
2 131 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.72 [1.37, 5.40]
5 Miscarriage rate per woman 3 157 Peto Odds Ratio (Peto, Fixed, 95% CI) 3.92 [0.85, 17.96]
5.1 IUI versus CI in
clomiphene-stimulated cycles
1 26 Peto Odds Ratio (Peto, Fixed, 95% CI) Not estimable
5.2 IUI versus CI in
gonadotrophin-stimulated
cycles
2 131 Peto Odds Ratio (Peto, Fixed, 95% CI) 3.92 [0.85, 17.96]
6 Multiple pregnancy rate per
woman
3 157 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.19 [0.79, 6.07]
6.1 IUI versus CI in
clomiphene-stimulated cycles
1 26 Peto Odds Ratio (Peto, Fixed, 95% CI) Not estimable
6.2 IUI versus CI in
gonadotrophin-stimulated
cycles
2 131 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.19 [0.79, 6.07]
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Analysis 1.1. Comparison 1 IUI versus CI in stimulated cycles with cryopreserved sperm, Outcome 1 Live
birth rate per woman after all treatment cycles.
Review: Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Comparison: 1 IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome: 1 Live birth rate per woman after all treatment cycles
Study or subgroup IUI CI
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 IUI versus CI in clomiphene-stimulated cycles
Hurd 1993 1/13 1/13 5.5 % 1.00 [ 0.06, 16.93 ]
Subtotal (95% CI) 13 13 5.5 % 1.00 [ 0.06, 16.93 ]
Total events: 1 (IUI), 1 (CI)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 IUI versus CI in gonadotrophin-stimulated cycles
Matorras 1996 26/47 16/41 63.7 % 1.91 [ 0.83, 4.39 ]
Wainer 1995 12/23 6/20 30.7 % 2.43 [ 0.73, 8.09 ]
Subtotal (95% CI) 70 61 94.5 % 2.07 [ 1.04, 4.10 ]
Total events: 38 (IUI), 22 (CI)
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.08 (P = 0.038)
Total (95% CI) 83 74 100.0 % 1.98 [ 1.02, 3.86 ]
Total events: 39 (IUI), 23 (CI)
Heterogeneity: Chi2 = 0.35, df = 2 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 2.02 (P = 0.044)
Test for subgroup differences: Chi2 = 0.24, df = 1 (P = 0.63), I2 =0.0%
0.01 0.1 1 10 100
Favours CI Favours IUI
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Analysis 1.2. Comparison 1 IUI versus CI in stimulated cycles with cryopreserved sperm, Outcome 2 Live
birth rate per woman after one treatment cycle.
Review: Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Comparison: 1 IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome: 2 Live birth rate per woman after one treatment cycle
Study or subgroup IUI CI
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 IUI versus CI in clomiphene-stimulated cycles
Hurd 1993 1/13 1/13 100.0 % 1.00 [ 0.06, 16.93 ]
Subtotal (95% CI) 13 13 100.0 % 1.00 [ 0.06, 16.93 ]
Total events: 1 (IUI), 1 (CI)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 IUI versus CI in gonadotrophin-stimulated cycles
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (IUI), 0 (CI)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 13 13 100.0 % 1.00 [ 0.06, 16.93 ]
Total events: 1 (IUI), 1 (CI)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CI Favours IUI
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Analysis 1.3. Comparison 1 IUI versus CI in stimulated cycles with cryopreserved sperm, Outcome 3
Pregnancy rate per woman after one treatment cycle.
Review: Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Comparison: 1 IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome: 3 Pregnancy rate per woman after one treatment cycle
Study or subgroup IUI CI
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 IUI versus CI in clomiphene-stimulated cycles
Hurd 1993 1/13 1/13 13.3 % 1.00 [ 0.06, 16.93 ]
Patton 1992 8/28 2/22 55.6 % 3.30 [ 0.83, 13.13 ]
Subtotal (95% CI) 41 35 68.9 % 2.62 [ 0.76, 9.07 ]
Total events: 9 (IUI), 3 (CI)
Heterogeneity: Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.52 (P = 0.13)
2 IUI versus CI in gonadotrophin-stimulated cycles
Wainer 1995 3/23 2/20 31.1 % 1.34 [ 0.21, 8.47 ]
Subtotal (95% CI) 23 20 31.1 % 1.34 [ 0.21, 8.47 ]
Total events: 3 (IUI), 2 (CI)
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
Total (95% CI) 64 55 100.0 % 2.12 [ 0.76, 5.95 ]
Total events: 12 (IUI), 5 (CI)
Heterogeneity: Chi2 = 0.90, df = 2 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Chi2 = 0.35, df = 1 (P = 0.55), I2 =0.0%
0.01 0.1 1 10 100
Favours CI Favours IUI
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Analysis 1.4. Comparison 1 IUI versus CI in stimulated cycles with cryopreserved sperm, Outcome 4
Pregnancy rate per woman after all treatment cycles.
Review: Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Comparison: 1 IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome: 4 Pregnancy rate per woman after all treatment cycles
Study or subgroup IUI CI
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 IUI versus CI in clomiphene-stimulated cycles
Hurd 1993 1/13 1/13 4.1 % 1.00 [ 0.06, 16.93 ]
Patton 1992 19/28 4/22 26.5 % 7.10 [ 2.34, 21.52 ]
Subtotal (95% CI) 41 35 30.5 % 5.47 [ 1.95, 15.35 ]
Total events: 20 (IUI), 5 (CI)
Heterogeneity: Chi2 = 1.60, df = 1 (P = 0.21); I2 =37%
Test for overall effect: Z = 3.22 (P = 0.0013)
2 IUI versus CI in gonadotrophin stimulated cycles
Matorras 1996 31/47 17/41 46.6 % 2.66 [ 1.15, 6.13 ]
Wainer 1995 13/23 6/20 22.9 % 2.86 [ 0.87, 9.42 ]
Subtotal (95% CI) 70 61 69.5 % 2.72 [ 1.37, 5.40 ]
Total events: 44 (IUI), 23 (CI)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.87 (P = 0.0042)
Total (95% CI) 111 96 100.0 % 3.37 [ 1.90, 5.96 ]
Total events: 64 (IUI), 28 (CI)
Heterogeneity: Chi2 = 2.83, df = 3 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 4.17 (P = 0.000030)
Test for subgroup differences: Chi2 = 1.22, df = 1 (P = 0.27), I2 =18%
0.01 0.1 1 10 100
Favours CI Favours IUI
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Analysis 1.5. Comparison 1 IUI versus CI in stimulated cycles with cryopreserved sperm, Outcome 5
Miscarriage rate per woman.
Review: Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Comparison: 1 IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome: 5 Miscarriage rate per woman
Study or subgroup IUI CI
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 IUI versus CI in clomiphene-stimulated cycles
Hurd 1993 0/13 0/13 Not estimable
Subtotal (95% CI) 13 13 Not estimable
Total events: 0 (IUI), 0 (CI)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 IUI versus CI in gonadotrophin-stimulated cycles
Matorras 1996 5/47 1/41 85.0 % 3.58 [ 0.69, 18.69 ]
Wainer 1995 1/23 0/20 15.0 % 6.49 [ 0.13, 329.99 ]
Subtotal (95% CI) 70 61 100.0 % 3.92 [ 0.85, 17.96 ]
Total events: 6 (IUI), 1 (CI)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.76 (P = 0.079)
Total (95% CI) 83 74 100.0 % 3.92 [ 0.85, 17.96 ]
Total events: 6 (IUI), 1 (CI)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.76 (P = 0.079)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IUI Favours CI
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Analysis 1.6. Comparison 1 IUI versus CI in stimulated cycles with cryopreserved sperm, Outcome 6
Multiple pregnancy rate per woman.
Review: Cervical insemination versus intra-uterine insemination of donor sperm for subfertility
Comparison: 1 IUI versus CI in stimulated cycles with cryopreserved sperm
Outcome: 6 Multiple pregnancy rate per woman
Study or subgroup IUI CI
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 IUI versus CI in clomiphene-stimulated cycles
Hurd 1993 0/13 0/13 Not estimable
Subtotal (95% CI) 13 13 Not estimable
Total events: 0 (IUI), 0 (CI)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 IUI versus CI in gonadotrophin-stimulated cycles
Matorras 1996 9/47 4/41 75.1 % 2.09 [ 0.65, 6.76 ]
Wainer 1995 3/23 1/20 24.9 % 2.54 [ 0.33, 19.49 ]
Subtotal (95% CI) 70 61 100.0 % 2.19 [ 0.79, 6.07 ]
Total events: 12 (IUI), 5 (CI)
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
Total (95% CI) 83 74 100.0 % 2.19 [ 0.79, 6.07 ]
Total events: 12 (IUI), 5 (CI)
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours IUI Favours CI
A D D I T I O N A L T A B L E S
Table 1. Study quality
Study Secure randomisa-
tion
Adequate conceal-
ment
Intention to treat Losses to follow up Notes
Hurd 1993 Yes, random num-
bers list
Using opaque con-
secutively numbered
envelopes
Yes None Local funding, i.e. un-
funded
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Table 1. Study quality (Continued)
Mattoras 1996 Yes, random number
table
Using opaque con-
secutively numbered
envelopes
No None Public funding
Patton 1992 Random assignment,
method unclear
Unclear No Dropouts: 9 ICI and
10 IUI
-
Wainer 1995 Yes, randomised lists Unclear Unclear Not stated -
WH A T ’ S N E W
Last assessed as up-to-date: 16 February 2008.
Date Event Description
20 September 2010 Amended Contact details updated.
H I S T O R Y
Protocol first published: Issue 4, 1998
Review first published: Issue 4, 1998
Date Event Description
6 November 2008 Amended Converted to new review format.
17 May 2007 New search has been performed This review was updated May 2007
17 February 2008 New citation required and conclusions have changed Substantive amendment
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